Get the full picture
Sign in to uncover key details.
Context Therapeutics
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.contexttherapeutics.infoRevenue
$100 MillionIndustry
About Context Therapeutics
Context Therapeutics is focused on advancing the treatment of female cancers through innovative T cell engaging bispecific antibody therapies. Their clinical-stage pipeline includes CTIM-76, CT-95, and CT-202, which are designed to leverage the immune system for targeted cancer eradication. The company aims to transform cancer care and improve outcomes for patients with challenging solid tumors. Context Therapeutics is dedicated to progressing their therapies from laboratory research to clinical application.Explore more
Context Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Context Therapeutics
Sign Up For FreeTo access detailed company insights
Context Therapeutics is focused on advancing the treatment of female cancers through innovative T cell engaging bispecific antibody therapies. Their clinical-stage pipeline includes CTIM-76, CT-95, and CT-202, which are designed to leverage the immune system for targeted cancer eradication. The company aims to transform cancer care and improve outc... Read More
